Australia markets closed

Xenon Pharmaceuticals Inc. (XENE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
34.16-1.17 (-3.31%)
At close: 04:00PM EDT
35.16 +1.00 (+2.93%)
After hours: 04:38PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
No. of analysts15151616
Avg. Estimate-0.77-0.8-2.93-3.38
Low estimate-0.89-0.94-3.15-3.95
High estimate-0.54-0.57-2.65-2.49
Year ago EPS-0.57-0.57-2.06-2.93
Revenue estimateCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
No. of analysts14141414
Avg. Estimate1.45M2.01M3.46M6.57M
Low estimateN/AN/AN/AN/A
High estimate17M15M23M40M
Year ago sales132kN/A9.43M3.46M
Sales growth (year/est)998.50%N/A-63.30%89.90%
Earnings history29/09/202230/12/202230/03/202329/06/2023
Est. EPS-0.52-0.58-0.62-0.7
Actual EPS-0.57-0.57-0.63-0.72
Difference-0.050.01-0.01-0.02
Surprise %-9.60%1.70%-1.60%-2.90%
EPS trendCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
Current estimate-0.77-0.8-2.93-3.38
7 days ago-0.77-0.8-2.93-3.38
30 days ago-0.77-0.8-2.93-3.38
60 days ago-0.72-0.75-2.81-3.2
90 days ago-0.72-0.75-2.81-3.2
EPS revisionsCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/A11
Up last 30 daysN/AN/A11
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesXENEIndustrySector(s)S&P 500
Current qtr.-35.10%N/AN/AN/A
Next qtr.-40.40%N/AN/AN/A
Current year-42.20%N/AN/AN/A
Next year-15.40%N/AN/AN/A
Next 5 years (per annum)57.80%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A